Vancouver-based healthtech company Well Health Technologies has completed the public listing of its software-focused subsidiary Wellstar Technologies Corp. The new entity began trading on the TSX Venture Exchange on October 1, 2026, under the ticker symbol WSTR. The listing is intended to separate Well Health's clinic operations from its clinical software tools and create a more focused public company.
Listing and Company Mandate
Wellstar's subordinate voting shares opened on the TSXV after the company completed its previously announced amalgamation with 1587818 B.C. Ltd. Wellstar describes itself as a leading provider of digital health solutions for Canadian healthcare providers, and more than 40% of practitioners currently use its products and services. Its portfolio includes billing and practice management systems, electronic medical record systems, digital health applications, and digital health network solutions.
Amir Javidan, Chief Executive Officer and Director of Wellstar, described the listing as an important milestone for the company. He thanked the Wellstar team, Well Health, customers, and shareholders for their support along the way. Javidan added that direct access to capital markets and a strengthened balance sheet would help drive innovation and transformation in the Canadian healthcare landscape.
Board Leadership and Governance
Wellstar's five-member board is led by Chairman Hamed Shahbazi and includes Chief Executive Officer Amir Javidan, director Evelyn Sutherland, and independent directors Matt Mattox and Sue Paish. The company said the board combines healthcare, technology, capital markets, and governance experience to support its next phase of growth. This governance structure is intended to provide a strong foundation as a public company.
Shahbazi is the founder, chairman, and chief executive officer of Well Health, which operates more than 275 outpatient medical clinics across Canada and generates annual revenue above $1.5 billion. Javidan previously served as Well Health's chief operating officer and helped build the company from its early stages into a national clinic network. Sutherland serves as Well Health's chief financial officer and chairs Wellstar's audit committee.
Market Support and Capital
To support orderly trading and liquidity, Wellstar has engaged Independent Trading Group as a market maker for a monthly fee of $6,000, subject to regulatory approval. The agreement has an initial term of one month and may be renewed for additional one month periods unless terminated by either party with 30 days of notice. Wellstar also retained Angad Capital for investor relations and capital markets advisory services at a monthly fee of $10,000 beginning October 1, 2026.
The listing follows nearly two years of preparation and capital raising ahead of the spin-out. According to the company, Wellstar has raised C$162 million in financings and roughly doubled its revenue during that period. These resources are expected to support continued execution and potential acquisition opportunities as the company scales.
Strategic Context
Well Health has said it expects to remain a significant long-term controlling shareholder and growing customer of Wellstar. The parent company has also pursued other growth initiatives, including obtaining majority control of Toronto-based Healwell AI. That transaction was substantial enough that Canada's federal competition watchdog obtained a court order to investigate its potential impact on healthcare technology and services.
Wellstar's public debut is a structured effort to create focused value for investors and customers in the Canadian digital health market. The listing separates clinical service delivery from software operations while maintaining a close strategic relationship with Well Health. With a new board, capital markets support, and a strengthened balance sheet, the company is positioned to pursue its next phase of growth.